Results 221 to 230 of about 273,783 (254)

Access to Medicines and the Safety of the People

Reviews on Recent Clinical Trials, 2015
In this paper I will attempt to outline what I believe to be the most persuasive and acceptable (although not necessarily as yet accepted) theoretical justifications for the widest possible access to medicines and for prioritising measures to increase this access.
openaire   +2 more sources

Providing access to medicines

Veterinary Record, 2023
openaire   +2 more sources

Widening access to medicine

British Journal of Hospital Medicine, 2011
Adam M, Hill, Joseph, Shalhoub
openaire   +2 more sources

Universal access to medicines

The Lancet, 2016
Louis W, Niessen, Jahangir A M, Khan
openaire   +2 more sources

Innovation and Access to Medicines

2021
This is a report commissioned by the Royal Netherlands Society of International Law (KNVIR) as part of its Preadviezen on the theme 'Global health law disrupted: Covid-19 and the climate crisis'. This report examines the role of and tensions between international trade and human rights law with regards to Innovation and Access to Medicines, and the ...
Perehudoff, K., Sellin, J.
openaire   +1 more source

Increasing access to medicines

BMJ, 2009
Roger, Finch, Sarah, Garner
openaire   +2 more sources

Revisiting the issue of access to medicines in Africa: Challenges and recommendations

Public Health Challenges, 2022
Aishat Alaran, John Oluwafemi Teibo, Mohamed Samai   +2 more
exaly  

Access to Medicines in India

2017
INTRODUCTION The second country study conducted in this research is on India. India is classified as a lower middle income country with a GNI per capita of US$ 1,330 (2010); it has a poverty headcount ratio of 37.2% of the population, life expectancy of 65 years, and a under-five mortality rate of 63.
openaire   +1 more source

[Access to medicines in France].

Bulletin de l'Academie nationale de medecine, 2009
In France the total cost of medicinal products reimbursed by health insurers in 2007 was over 25 thousand million euros, and access to new drugs is neither restricted nor rationed, despite the unfavorable economic situation. In 2007 and 2008 the Transparency Commission (TC) of the French National Authority for Health (Haute Autorité de Santé) approved ...
Gilles, Bouvenot, Julien, Bouvenot
openaire   +1 more source

Enhancing global access to cancer medicines

Ca-A Cancer Journal for Clinicians, 2020
Alexandru Eniu, Cortes J, Nagi El Saghir   +2 more
exaly